Greater frequency of CD5-negative CD8+ T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation

Table 2 General characteristics of HIV-infected study subjects

ID	Age (years)	Sex	Duration of HIV infection (years)	CD4⁺T cells/μL peripheral blood	Virus load^a	Treatment^b
11	44	Female	>20	200	2.81	cART
12	40	Male	>20	518	<1.6	cART
18	37	Male	>20	729	1.97	cART
28	45	Male	>20	144	4.94	None
30	50	Male	>20	884	<1.6	cART
34	37	Female	>20	450	3.26	cART
35	52	Male	>25	882	1.6	cART
39	38	Female	>20	506	2.74	cART
43	49	Male	>20	450	4.15	None
45	42	Female	>20	456	<1.6	cART
62	38	Female	>20	720	<1.6	cART
65	54	Female	>20	306	<1.6	cART
71	38	Female	>20	860	<1.6	cART
78	41	Male	>20	150	2.73	cART
90	42	Female	>10	315	<1.6	cART
92	36	Female	>15	325	5.5	None
96	44	Female	>15	812	<1.6	cART
105	46	Male	>10	527	2.15	cART
115	44	Female	>10	704	<1.6	cART
117	45	Male	>15	322	<1.6	cART
125	51	Male	>10	420	<1.6	cART
126	50	Male	>10	754	<1.6	cART
132	37	Female	>15	30	5.53	None
134	44	Female	>20	780	<1.6	cART
151	54	Male	>10	360	<1.6	cART
154	47	Male	>20	442	<1.6	cART
155	41	Female	>5	500	<1.6	cART
179	44	Male	>5	984	<1.6	cART
181	39	Male	>20	104	4.79	None
193	43	Female	>5	420	<1.6	cART
196	54	Male	>5	273	<1.6	cART
197	59	Male	>5	616	<1.6	cART
201	52	Male	>5	434	<1.6	cART
204	42	Female	>20	437	<1.6	cART
213	55	Female	>5	561	<1.6	cART

^aVirus load is expressed in log₁₀ copies HIV RNA/ml plasma.
^bCombination antiretroviral therapy (cART) represents various two or three class highly active antiretroviral drug regimens.

ISSN: 1742-6405